프로포폴 주사 시장 : 제품 유형별, 용도별, 제제별, 최종사용자별, 유통 채널별, 지역별

Propofol Injection Market is estimated to be valued at USD 1.62 Bn in 2025 and is expected to reach USD 3.02 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

The global propofol injection market represents a critical segment within the pharmaceutical industry, encompassing one of the most widely utilized intravenous anesthetic agents in modern medical practice. Propofol, chemically known as 2,6-diisopropylphenol, serves as a short-acting sedative-hypnotic agent primarily employed for induction and maintenance of general anesthesia, as well as sedation in intensive care units and procedural settings. This injectable formulation has revolutionized anesthetic practices globally due to its rapid onset, controllable depth of sedation, and swift recovery profile with minimal residual effects.

The market encompasses various concentrations and formulations of propofol injections, catering to diverse medical applications including surgical procedures, diagnostic interventions, and critical care management. Healthcare institutions, including hospitals, ambulatory surgical centers, and specialty clinics, constitute the primary end-users driving market demand. The increasing prevalence of surgical procedures, growing geriatric population requiring medical interventions, and expanding outpatient surgical facilities significantly contribute to market expansion. Additionally, the rising adoption of propofol in emerging markets, coupled with continuous research and development initiatives for improved formulations, positions this market as a vital component of the global anesthesia pharmaceutical landscape.

Market Dynamics

The global propofol injection market is propelled by several compelling drivers, with the foremost being the exponential increase in surgical procedures worldwide, driven by an aging population requiring various medical interventions, from routine surgeries to complex operations. The growing prevalence of chronic diseases necessitating surgical treatments, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging economies, significantly boosts the market demand. Additionally, the preference for propofol over traditional anesthetic agents due to its superior pharmacokinetic properties, including rapid onset and recovery, minimal side effects, and excellent patient tolerance, drives adoption across healthcare facilities. However, the market faces notable restraints, primarily centered around stringent regulatory requirements for anesthetic drugs, which often result in lengthy approval processes and substantial compliance costs for manufacturers.

The potential for abuse and diversion of propofol, highlighted by high-profile cases, has led to increased regulatory scrutiny and controlled substance scheduling in various jurisdictions, creating additional barriers for market accessibility. Furthermore, the requirement for specialized storage conditions and skilled administration limits its usage in resource-constrained settings. Despite these challenges, significant opportunities emerge from the expanding outpatient surgical procedures market, where propofol's rapid recovery profile is particularly advantageous. The development of novel formulations, including lipid-free alternatives and enhanced stability versions, presents lucrative growth prospects. Additionally, increasing healthcare awareness in developing nations, expanding medical tourism, and the growing trend toward minimally invasive procedures create substantial market opportunities for propofol injection manufacturers and distributors globally.

Key Features of the Study

• This report provides in-depth analysis of the global propofol injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global propofol injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include leading Fresenius Kabi, Baxter International, B. Braun Melsungen AG, AbbVie Inc., Pfizer Inc., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis division), Dr. Reddy's Laboratories, Guangdong Jiabo Pharmaceutical, Xian Libang Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Sinopharm Guorui Pharmaceutical, Midas Pharma, and Emcure Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global propofol injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global propofol injection market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Generic
  • Branded
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Short-term Sedation (Procedural Sedation)
  • Endoscopy (Colonoscopy, Upper GI Endoscopy)
  • Bronchoscopy
  • Cardioversion
  • Minor Surgical Procedures
  • Long-term Sedation (Intensive Care Unit - ICU)
  • Induction and Maintenance of Anesthesia
• Formulation Insights (Revenue, USD Bn, 2020 - 2032)
  • Single-Dose Vials
  • Multi-Dose Vials
  • Pre-filled Syringes
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Others (e.g., Recovery Centers)
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Fresenius Kabi
  • Baxter International
  • Braun Melsungen AG
  • AbbVie Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Reddy's Laboratories
  • Guangdong Jiabo Pharmaceutical
  • Xian Libang Pharmaceutical
  • Jiangsu Nhwa Pharmaceutical
  • Sinopharm Guorui Pharmaceutical
  • Midas Pharma
  • Emcure Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Propofol Injection Market, By Product Type
  • Global Propofol Injection Market, By Application
  • Global Propofol Injection Market, By Formulation
  • Global Propofol Injection Market, By End User
  • Global Propofol Injection Market, By Distribution Channel
  • Global Propofol Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Propofol Injection Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Branded
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Propofol Injection Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Short-term Sedation (Procedural Sedation)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Endoscopy (Colonoscopy, Upper GI Endoscopy)
    • Bronchoscopy
    • Cardioversion
    • Minor Surgical Procedures
• Long-term Sedation (Intensive Care Unit - ICU)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Induction and Maintenance of Anesthesia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Propofol Injection Market, By Formulation, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multi-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pre-filled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Propofol Injection Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., Recovery Centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Propofol Injection Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Propofol Injection Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Fresenius Kabi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sandoz (a Novartis division)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reddy's Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Guangdong Jiabo Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Xian Libang Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Nhwa Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinopharm Guorui Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Midas Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Emcure Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us